Papers on COVID-19 in Psoriasis, Psoriatic Arthritis Carry Risk for Bias
WEDNESDAY, Aug. 4, 2021 -- Published papers addressing the risk and outcomes of COVID-19 in patients with psoriasis and psoriatic arthritis receiving biologic therapies have a high risk for bias, according to a study published online Aug. 4 in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Arthritis | COVID-19 | Pharmaceuticals | Psoriasis | Psoriatic Arthritis | Rheumatology | Study